Hazardous chemical splatter during liver chemoembolization.
Gaba
Ron C
RC
Department of Radiology, Section of Interventional Radiology, Universityof Illinois at Chicago, Chicago, IL 60612, USA. rgaba@uic.edu
D000059:Accidents; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects* / Q000295:instrumentation; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004867:Equipment Design; D004868:Equipment Failure; D015386:Hazardous Substances / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects; D016273:Occupational Exposure; D018570:Risk Assessment; D017751:Safety Management; D013594:Syringes
D015386:Hazardous Substances; D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin